GlassScriptPhysician profile
Cameron R Good
NPI 1558817395
$734.98
in general payments reported to CMS, 2019-2025
14 companies · $564 in 2025
The $564 reported for 2025 was more than what 75% of Nurse Practitioner providers received nationally (typical 2025 total: $174).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $171 · 2025: $564.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $735.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $734.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| 180 Medical, INC. | $112.15 | 2024-2025 | Gentlecath Glide, Gentlecath |
| Janssen Biotech, INC. | $102.51 | 2025 | Rybrevant, Carvykti, Erleada |
| Astellas Pharma US INC | $97.98 | 2025 | Xtandi |
| Convatec INC. | $75.94 | 2025 | |
| Ferring Pharmaceuticals INC. | $73.87 | 2024-2025 | Adstiladrin |
| Urogen Pharma, INC. | $58.78 | 2024-2025 | |
| Laborie Medical Technologies Corp. | $42.54 | 2025 | |
| Blue Earth Diagnostics | $33.68 | 2025 | Posluma |
| Becton, Dickinson and Company | $29.18 | 2025 | Bard Urinary Drainage Bag |
| Antares Pharma, INC. | $25.35 | 2025 | Xyosted |
| Calyxo, INC. | $24.08 | 2024 | Cvac Aspiration System |
| Axonics, INC. | $20.89 | 2024 | Axonics |
| Immunitybio, INC. | $19.07 | 2024 | |
| Progenics Pharmaceuticals, INC. | $18.96 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cameron Good listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.